23rd Annual Hypertension, Diabetes & Dyslipidemia Conference
23rd Annual Hypertension, Diabetes & Dyslipidemia Conference is organized by Continuing Education Company, Inc. (CEC) and will be held from Jun 21 - 23, 2019 at Hyatt Place Charleston/Historic District, Charleston, South Carolina, United States of America.
The target audience for this medical event is Physicians specializing in Internal Medicine, Family or General Practice, Geriatric Medicine, Endocrinology, Lipidology and Hypertension Specialists. Healthcare professionals including physician assistants and nurse practitioners specializing in these areas or those managing patients with Hypertension, Diabetes, and/or Hyperlipidemia, alone or in combination, may benefit from this activity.
Earn a total of 30 credits with our Special CME Offer! Attend the 23rd Annual Hypertension, Diabetes & Dyslipidemia Conference (15 CME Credits) and you will receive a FREE online 15 credit CME course from CME365.*
AAFP: This live activity, 23rd Annual Hypertension, Diabetes, and Dyslipidemia Conference, with a beginning date of June 21, 2019 has been reviewed and is acceptable for up to 15.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Company designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CFPC: Members of the College of Family Physicians of Canada are eligible to receive 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
This three day intensive conference, addresses all the issues confronting clinicians who treat challenging patients with diabetes, hypertension, and dyslipidemia and how to apply this knowledge to everyday practice.
Over the past several years controversies in the appropriate level of Hemoglobin A1C, BP, and LDL-Cholesterol for outcome improvement continue to occur in Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Despite the results from the ACCORD, VADT, and ADVANCE studies suggesting the benefits on reducing macrovascular disease with a more intensive strategy for A1C reduction remains unclear, individualized A1C targets for those with newly diagnosed diabetes compared to those with long standing disease are often recommended. In addition, controversy continues to exist in cholesterol control as recent guidelines suggest that one should decide on the intensity of statin-based therapy for outcome improvement in those at risk for or with established ASCVD rather than a specific goal of LDL-cholesterol reduction. Finally, the recent SPRINT trial has suggested that lower targets for BP reduction than ever achieved before can and should be achieved in high-risk adults with hypertension.
This conference will address these and other issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to apply these important clinical principles back to their everyday practice to improve the care of their patients.
Program Objectives are:
As a result of this educational activity, participants should be better able to:
• Formulate an efficient and effective assessment and monitoring plan of a patient's condition as it relates to hypertension, diabetes, and dyslipidemia.
• Utilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.
• Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will lead to the reduction of modifiable risk factors and improved long term outcomes.
|Contact No. :||(800) 327-4502
|Registration Type||End Date||Price|
|Physicians Conference Fee||23 Jun,2019||USD 610.00|
|Residents and other healthcare professionals Conference Fee||23 Jun,2019||USD 585.00|